Route 92 Medical

Route 92 Medical is a California-based medical technology company focused on enhancing outcomes for patients undergoing neurovascular interventions, particularly in acute ischemic stroke treatment. Founded by physicians, the company collaborates with leading neurovascular clinicians to create innovative products that address challenges in neurointervention. The company offers a range of neurovascular reperfusion systems designed for endovascular thrombectomy procedures. Their flagship products include the FreeClimb® Catheter Systems, which are effective for clot removal, and Tenzing® Delivery Catheters that ensure precise navigation during procedures. Additionally, the HiPoint® and Monopoint® Reperfusion Systems are part of ongoing clinical evaluations to assess their safety and effectiveness in stroke treatment. Route 92 Medical has a strong intellectual property portfolio with over 100 patents globally, protecting its inventions related to arterial and venous access in the brain. The company is committed to advancing neurovascular intervention and improving patient outcomes through its innovative solutions.

• Employees 190
• Founded 2015
• Annual Revenue $5000000
• Total Funding $324782044